Webinars.

Educational insights about GARD

When you watch our webinars, you will learn in what ways GARD can support your testing needs. We cover essential topics that range from genomics and machine learning and why GARD has such robust prediction for in vitro sensitization testing, to difficult-to-test samples and quantitative potency assessment.

© SenzaGen

Interested in more information?

Contact us to discuss how the GARD assays can support your testing needs.

September 15, 2020
Joint webinar: Your Guide to GARD®
– New generation skin sensitisation testing technologies explained

By Carol Treasure, PhD, XCellR8 and Andy Forreryd, PhD, SenzaGen AB

June 17, 2020
Web-based launch: The NEW GARDskin Dose-Response
By Andy Forreryd, PhD, SenzaGen AB

View webinar

May 26, 2020
Genomics and Machine Learning for In Vitro Sensitization Testing of Challenging Chemicals
By Henrik Johansson, PhD, and Andy Forreryd, PhD, SenzaGen AB

March 26, 2020
Web-based conference on “Difficult-to-test” substances and regulatory testing
By Andy Forreryd, SenzaGen AB and guest speakers from Eurofins, Lubrizol and MB Research Labs

Session recordings
Dr Andy Forreryd, SenzaGen
Helge Gehrke, Eurofins BioPharma Product Testing
Dr. George DeGeorge, MB Research Labs

February, 2020

In vitro sensitization testing based on genomics and machine learning
By Angelica Johansson, SenzaGen AB

October, 2019

In vitro sensitization testing of Medical Devices – GARDskin Medical Device 
By Rose-Marie Jenvert, PhD, SenzaGen

September 2019

How are the in vitro GARD™ assays used in real life? – Cases and applications for testing of skin and respiratory sensitizers
By Andy Forreryd, PhD, SenzaGen

April 2019

Genomics and Machine Learning – All you need to know about the GARD™ technology for in vitro sensitization testing
By Andy Forreryd, PhD, SenzaGen

December 2018

In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARDtechnology platform
By Andy Forreryd, PhD, SenzaGen

May 2018

Sensitization testing and hazard assessment using functional genomics with GARD
By Henrik Johansson, PhD, SenzaGen